arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Purple Biotech Ltd.

PPBT Health Care Biotechnology: Pharmaceutical Preparations
$1.05
▼ -3.2% Today
as of Oct 22, 16:51 ET
Last 30 days -40.34% Sep 14 → Oct 22
$0.99 $1.20 $1.40 $1.61 $1.82 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$1.15
High
$1.15
Low
$1.05
Volume
$19,301
Avg Vol
$588,681
Mkt Cap
$2M
P/E (TTM)
—
Beta
—
52w High
$14.10
52w Low
$1.05
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 1 item

Sep 2 · 15:07 InvestorsHub
Purple Biotech U.S. Patent Allowance Strengthens CAPTN-3 Multispecific Antibody Protection

PPBT earnings at a glance

The options market is pricing a move of about ±8.3% after the report, a range of roughly $0.96 to $1.14 from today's $1.05. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±4.2% on average; after the most recent report on May 15, 2026 it moved +6.8%. That means options currently expect more movement than PPBT has typically delivered. PPBT beat the consensus EPS estimate in 1 of its last 3 reported quarters. Implied volatility is currently 66%. The share price of $1.05 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$1.05
$14
0% of range
Avg surprise (last 3)
-1.5%
Avg reaction (last 2)
+2.6%
50% positive
Latest IV / EM
66%
EM ±8.3% · $3 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-3.80$-2.87$-1.94$-1.02$-0.09 Actual $-0.17Actual $-0.40Est $-0.21Actual $-0.29Est $-0.26Actual $-0.09Est $-3.80 Mar/2025Jun/2025Sep/2025Mar/2026

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Fri May 15, 2026Mar/2026 $-0.09 $-3.80 +97.6% +47.1% +6.8% earnings
Fri Nov 14, 2025Sep/2025 $-0.29 $-0.26 -11.5% — — earnings
Wed Aug 6, 2025Jun/2025 $-0.40 $-0.21 -90.5% — — earnings
Wed May 21, 2025Mar/2025 $-0.17 — — — -1.7% earnings

Implied volatility — last 90 days

46%1174%2302%3429%4557% Jun 08 — IV 739% · EM ±97.6%Jun 09 — IV 747% · EM ±93.6%Jun 10 — IV 793% · EM ±93.6%Jun 11 — IV 882% · EM ±97.4%Jun 12 — IV 1143% · EM ±116.9%Jun 15 — IV 3215% · EM ±232.6%Jun 16 — IV 4312% · EM ±254.7%Jun 17 — IV 4558% · EM ±190.3%Jun 26 — IV 47% · EM ±8.9%Jun 29 — IV 49% · EM ±8.6%Jun 30 — IV 52% · EM ±8.9%Jul 01 — IV 735% · EM ±122.9%Jul 02 — IV 1473% · EM ±238.2%Jul 03 — IV 1525% · EM ±238.2%Jul 06 — IV 1690% · EM ±234.1%Jul 07 — IV 1917% · EM ±253.1%Jul 08 — IV 1995% · EM ±250.0%Jul 09 — IV 2039% · EM ±240.9%Jul 10 — IV 2299% · EM ±254.0%Aug 27 — IV 46% · EM ±9.1%Aug 28 — IV 49% · EM ±9.3%Sep 02 — IV 256% · EM ±42.7%Sep 03 — IV 335% · EM ±54.1%Sep 04 — IV 127% · EM ±19.8%Sep 07 — IV 144% · EM ±20.0%Sep 08 — IV 84% · EM ±11.1%Sep 09 — IV 66% · EM ±8.3%

Sector peers

MTNB
Matinas Biopharma Holdings, Inc.
$2M $1.71+0.6%
ARTL
Artelo Biosciences, Inc.
$2M $2.55-2.7%
REVB
Revelation Biosciences, Inc.
$3M $3.68+2.2%
DCOY
Decoy Therapeutics Inc.
$3M $1.03-9.2%
CDT
CDT Equity Inc.
$1M $0.13-18.2%
ERNA
Ernexa Therapeutics Inc.
$4M $2.08-7.4%

PPBT earnings FAQ

What is PPBT's expected move for earnings?

Options currently price a move of about ±8.3%, or $0.09 per share either way from $1.05.

How does PPBT stock usually react to earnings?

Across the last 2 reports the average next-day move was ±4.2%, up 1 times and down 1 times.

What is PPBT's implied volatility?

PPBT's at-the-money implied volatility is about 66% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in